Illumina entered into a $750 million five-year revolving credit agreement with Bank of America to finance its working capital needs and for general corporate purposes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,